This inventor holds 1 USPTO granted patent. Top assignee: Ensemble Therapeutics Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Wei-Chuan Sun in Tumor Necrosis Factor Alpha Inhibition
Introduction
Wei-Chuan Sun is an accomplished inventor based in Menlo Park, CA. He has made significant contributions to the field of medical research, particularly in the development of macrocyclic compounds aimed at inhibiting tumor necrosis factor alpha. His work has implications for treating various medical conditions, including rheumatoid arthritis, psoriasis, and asthma.
Latest Patents
Wei-Chuan Sun holds a patent for "Macrocyclic compounds for inhibition of tumor necrosis factor alpha." This patent discloses macrocyclic compounds and methods for their synthesis and use. The compounds are designed to modulate the activity of tumor necrosis factor alpha, which plays a crucial role in inflammatory processes.
Career Highlights
Wei-Chuan Sun is associated with Ensemble Therapeutics Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve treatment options for patients suffering from chronic inflammatory diseases.
Collaborations
Some of his notable coworkers include Nicholas K Terrett and Frank G Favaloro, Jr. Their collaborative efforts contribute to the ongoing research and development in the field of therapeutic compounds.
Conclusion
Wei-Chuan Sun's innovative work in the development of macrocyclic compounds represents a significant advancement in the treatment of inflammatory diseases. His contributions continue to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile